Profile
Lida Pacaud is currently Chief Executive & Medical Officer at Ichnos Glenmark Innovation, Inc. starting in 2025.
Formerly, Dr. Pacaud was Vice President-Clinical Development at Legend Biotech Corp.
from 2021 to 2023 and Head-Global Clinical Program at Novartis International AG from 2013 to 2021.
Education includes a doctorate from Tbilisi State Medical University.
Lida Pacaud active positions
| Companies | Position | Start |
|---|---|---|
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Chief Executive Officer | 2025-12-05 |
Former positions of Lida Pacaud
| Companies | Position | End |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Chief Tech/Sci/R&D Officer | 2023-05-31 |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | 2020-12-31 |
Training of Lida Pacaud
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Legend Biotech Corp.
Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Tbilisi State Medical University
Tbilisi State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Lida Pacaud
















